Clorprenaline HCl (NSC-334693; NSC334693; NSC 334693), the hydrochloride salt of Clorprenaline, is a potent β2-receptor agonist used as a bronchodilator with a significant expansion of the bronchial effect.
Physicochemical Properties
| Molecular Formula | C11H17CL2NO | |
| Molecular Weight | 250.16 | |
| Exact Mass | 267.079 | |
| Elemental Analysis | C, 52.81; H, 6.85; Cl, 28.34; N, 5.60; O, 6.40 | |
| CAS # | 6933-90-0 | |
| Related CAS # | 3811-25-4; 6933-90-0 (hydrochloride) | |
| PubChem CID | 23360 | |
| Appearance | White to off-white solid powder | |
| Boiling Point | 329.7ºC at 760 mmHg | |
| Melting Point | 165-169ºC | |
| Flash Point | 153.2ºC | |
| LogP | 3.564 | |
| Hydrogen Bond Donor Count | 3 | |
| Hydrogen Bond Acceptor Count | 2 | |
| Rotatable Bond Count | 4 | |
| Heavy Atom Count | 15 | |
| Complexity | 163 | |
| Defined Atom Stereocenter Count | 0 | |
| SMILES | ClC1=C([H])C([H])=C([H])C([H])=C1C([H])(C([H])([H])N([H])C([H])(C([H])([H])[H])C([H])([H])[H])O[H].Cl[H] |
|
| InChi Key | CPCPUCRSKRHVAH-UHFFFAOYSA-N | |
| InChi Code | InChI=1S/C11H16ClNO.ClH/c1-8(2)13-7-11(14)9-5-3-4-6-10(9)12;/h3-6,8,11,13-14H,7H2,1-2H3;1H | |
| Chemical Name | 1-(2-chlorophenyl)-2-(propan-2-ylamino)ethanol;hydrochloride | |
| Synonyms |
|
|
| HS Tariff Code | 2934.99.9001 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | β2-receptor | ||
| ln Vitro |
|
||
| ln Vivo |
|
||
| Animal Protocol |
|
||
| References |
[1]. J Pharm Biomed Anal . 2005 Jun 1;38(1):166-72. [2]. Chromatographia, 1999, 49(7-8), 141-144. [3]. Yao Xue Xue Bao . 1990;25(5):357-61. |
||
| Additional Infomation | Clorprenaline Hydrochloride is the hydrochloride salt form of clorprenaline, a beta-2 adrenergic agonist with bronchodilator activity. Clorprenaline selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle. This increases air flow and prevents bronchospasms and may eventually lead to an improvement of airway function. |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.99 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.99 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.99 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 100 mg/mL (399.74 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.9974 mL | 19.9872 mL | 39.9744 mL | |
| 5 mM | 0.7995 mL | 3.9974 mL | 7.9949 mL | |
| 10 mM | 0.3997 mL | 1.9987 mL | 3.9974 mL |